<tbody id="grid1_body_tbody"><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_0_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="0" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_0_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="1" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>싸이토젠(217330)</nobr></td><td datatype="" displayformat="" id="grid1_cell_0_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="2" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>싸이토젠-CTC 기반 액체생검의 강자<br>ㅁ 순환종양세포(CTC) 분리 검출 기술 기반 바이오테크<br>ㅁ 2024년은 매출 발생의 원년, 독보적인 기술력 기반 파트너쉽 다수</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_0_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="3" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Not Rated</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_0_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="4" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr></nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_0_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="5" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>15,910</nobr></td><td datatype="text" displayformat="" id="grid1_cell_0_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="6" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>대신증권</nobr></td><td id="grid1_cell_0_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="7" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>한송협</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_1_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="8" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_1_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="9" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>이노션(214320)</nobr></td><td datatype="" displayformat="" id="grid1_cell_1_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="10" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>이노션-실적 추이 및 전망<br>ㅁ Investment Point: 1) 캡티브 중심 안정적 성장 지속, 2) M&amp;A 가시화되며 디지털 역량 내재화<br>ㅁ 1) 계열 중심 대행 증가 및 신차 모멘텀 이어지며 본사, 해외 모두 캡티브 중심의 외형 성장 기대<br>ㅁ 2) 2023년 다양한 디지털 관련 기업들 순차적으로 인수하며 디지털 역량 내재화하고 있으며 그 효과는 내년부터 본격화되며 연결 실적에 유의미한 기여할 것으로 전망. 다양한 분야로의 크고 작은 투자 성과 이어지며 구조적으로 체질 개선하는 점 긍정적</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_1_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="11" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_1_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="12" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>58,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_1_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="13" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>42,350</nobr></td><td datatype="text" displayformat="" id="grid1_cell_1_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="14" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>유진투자증권</nobr></td><td id="grid1_cell_1_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="15" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>이현지</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_2_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="16" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_2_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="17" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>알에프에이치아이씨(218410)</nobr></td><td datatype="" displayformat="" id="grid1_cell_2_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="18" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>RFHIC-예상외로 4분기 실적은 좋을 것 같습니다<br>ㅁ 매수/목표가 4만원 유지, 이벤트 발생 시점 예측하면 지금이 매수 적기라 판단<br>ㅁ 2023년 4분기 실적 우려보다 양호할 듯, 방산 부문이 효자 역할 수행할 전망<br>ㅁ 5G Advanced 상용화 이슈화될 때 발표 실적 좋아 주가 상승 기대감 커질 듯</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_2_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="19" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_2_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="20" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>40,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_2_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="21" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>15,600</nobr></td><td datatype="text" displayformat="" id="grid1_cell_2_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="22" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하나증권</nobr></td><td id="grid1_cell_2_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="23" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>김홍식.고연수</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_3_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="24" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_3_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="25" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>젠큐릭스(229000)</nobr></td><td datatype="" displayformat="" id="grid1_cell_3_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="26" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>젠큐릭스-정밀의료 암진단의 숨겨진 강자<br>ㅁ PCR 기반 정밀의료 암 진단 전 주기 포트폴리오 보유<br>ㅁ 24년은 유방암 예측검사(진스웰 BCT) 매출 본격화 원년<br>ㅁ 암 진단 관련 다양한 포트폴리오 확보: 동반진단, 조기진단 시장 진출</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_3_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="27" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Not Rated</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_3_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="28" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr></nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_3_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="29" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>5,980</nobr></td><td datatype="text" displayformat="" id="grid1_cell_3_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="30" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>대신증권</nobr></td><td id="grid1_cell_3_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="31" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>한송협</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_4_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="32" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_4_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="33" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>엔비티(236810)</nobr></td><td datatype="" displayformat="" id="grid1_cell_4_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="34" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>엔비티-경기 침체에도 독보적인 성장, 글로벌 진출 본격화<br>ㅁ 대부분의 광고 기업들 실적 역성장한 반면, 엔비티는 창립 사상 최대 실적<br>ㅁ 네이버웹툰 북미에 이어 인도네시아, 태국, 대만까지 단독으로 서비스 개시<br>ㅁ 내년부터 매우 가파른 성장 예상, 지금부터 주목이 필요한 시점</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_4_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="35" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Not Rated</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_4_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="36" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr></nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_4_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="37" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>7,580</nobr></td><td datatype="text" displayformat="" id="grid1_cell_4_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="38" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하나증권</nobr></td><td id="grid1_cell_4_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="39" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>최재호.박희철</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_5_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="40" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_5_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="41" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>에이치케이이노엔(195940)</nobr></td><td datatype="" displayformat="" id="grid1_cell_5_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="42" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>HK이노엔-호재로 가득할 2024년<br>ㅁ 2024년 전망 및 핵심 투자 포인트 정리. 차선호주로 제시<br>ㅁ 케이캡의 중국 로열티 및 수출 매출 성장 이어지고, 국내 파트너사와의 신규 판매 계약에 따른 수익성 개선 예상<br>ㅁ 2024년 매출액 9,299억원(+11.6% YoY), 영업이익 964억원 (+45.3% YoY; OPM 10.4%)으로 추정</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_5_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="43" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_5_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="44" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>55,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_5_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="45" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>41,550</nobr></td><td datatype="text" displayformat="" id="grid1_cell_5_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="46" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>다올투자증권</nobr></td><td id="grid1_cell_5_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="47" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>이지수.임도영</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_6_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="48" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_6_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="49" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>에스티팜(237690)</nobr></td><td datatype="" displayformat="" id="grid1_cell_6_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="50" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>에스티팜-상업화 원료 2개에서 최대 5개로<br>ㅁ 차곡차곡 상용화 제품 쌓여간다<br>ㅁ 제품 믹스 개선 기대</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_6_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="51" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_6_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="52" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>110,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_6_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="53" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>68,500</nobr></td><td datatype="text" displayformat="" id="grid1_cell_6_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="54" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>키움증권</nobr></td><td id="grid1_cell_6_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="55" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>허혜민</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_7_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="56" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_7_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="57" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>클리오(237880)</nobr></td><td datatype="" displayformat="" id="grid1_cell_7_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="58" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>클리오-미라CLIO<br>ㅁ 최근 뷰티 트렌드(인디브랜드 수요↑+ 非중국향 글로벌 저변 확대) 스토리에 가장 적합한 업체<br>ㅁ 국내 H&amp;B, 온라인향 수요 및 글로벌 포트폴리오 다변화하며 고성장 지속, 이에 따른 영업 레버리지 효과 가시화될 것</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_7_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="59" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_7_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="60" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>40,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_7_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="61" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>29,250</nobr></td><td datatype="text" displayformat="" id="grid1_cell_7_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="62" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>현대차증권</nobr></td><td id="grid1_cell_7_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="63" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하희지</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_8_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="64" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_8_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="65" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성바이오로직스(207940)</nobr></td><td datatype="" displayformat="" id="grid1_cell_8_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="66" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성바이오로직스-명확해진 실적 방향성<br>ㅁ 2024년 전망 및 핵심 투자 포인트 정리<br>ㅁ CMO 경쟁사들 가이던스와는 상반되게 동사는 견조한 실적 성장 보여주고 있음<br>ㅁ 2024년 매출액 4조 2,104억원(+14.5% YoY), 영업이익 1조 1,962억원(+9.6% YoY; OPM 28.4%) 기록 예상</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_8_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="67" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_8_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="68" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>1,000,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_8_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="69" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>721,000</nobr></td><td datatype="text" displayformat="" id="grid1_cell_8_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="70" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>다올투자증권</nobr></td><td id="grid1_cell_8_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="71" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>이지수.임도영</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_9_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="72" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_9_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="73" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>넷마블(251270)</nobr></td><td datatype="" displayformat="" id="grid1_cell_9_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="74" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>넷마블-수익성 개선이 숙제<br>ㅁ 2024년 매출액 2조 5,967억원(+4.6%yoy), 영업이익 215억원(흑자전환yoy) 전망<br>ㅁ 동사는 흥행 신작 부재와 인건비, 감가상각비 등의 고정비 증가로 1분기 이후 7개 분기 연속 적자 기록<br>ㅁ 다만 큰 폭의 영업이익 흑자를 전망하기엔 아직 이른 단계라고 판단됨. 투자의견 HOLD 하향조정 및 목표주가 47,000원 유지</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_9_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="75" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>HOLD</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_9_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="76" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>47,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_9_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="77" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>52,700</nobr></td><td datatype="text" displayformat="" id="grid1_cell_9_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="78" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>유진투자증권</nobr></td><td id="grid1_cell_9_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="79" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>정의훈</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_10_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="80" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_10_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="81" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>크래프톤(259960)</nobr></td><td datatype="" displayformat="" id="grid1_cell_10_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="82" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>크래프톤-실적과 신작을 모두 갖췄다<br>ㅁ 2024년 매출액 1조 9,137억원(+5.8%yoy), 영업이익 6,677억원(-4.3%yoy) 전망<br>ㅁ 악재로 작용했던 BGMI의 서비스 중단과 글로벌 펍지모바일의 부진, 그리고 신작 부재가 점진적으로 해소되는 중<br>ㅁ 신작 라인업 확보 및 기존 게임들의 안정적인 매출 기대로 크래프톤을 게임 업종 내 최선호주로 추천</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_10_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="83" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_10_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="84" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>220,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_10_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="85" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>208,000</nobr></td><td datatype="text" displayformat="" id="grid1_cell_10_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="86" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>유진투자증권</nobr></td><td id="grid1_cell_10_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="87" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>정의훈</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_11_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="88" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_11_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="89" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>펄어비스(263750)</nobr></td><td datatype="" displayformat="" id="grid1_cell_11_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="90" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>펄어비스-구슬이 서 말이라도 꿰어야 보배<br>ㅁ 2024년 매출액 5,227억원(+54.2%yoy), 영업이익 1,010억원(흑자전환yoy) 전망<br>ㅁ 검은사막 유저트래픽 유지를 위해 글로벌 행사를 비롯한 많은 노력이 있었지만 장기화된 IP로 인한 매출 자연 감소는 불가피. 신작 출시의 필요성이 커지고 있음<br>ㅁ 투자의견 HOLD 및 목표주가 42,000원 하향조정</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_11_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="91" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>HOLD</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_11_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="92" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>42,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_11_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="93" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>41,250</nobr></td><td datatype="text" displayformat="" id="grid1_cell_11_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="94" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>유진투자증권</nobr></td><td id="grid1_cell_11_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="95" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>정의훈</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_12_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="96" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_12_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="97" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>스튜디오드래곤(253450)</nobr></td><td datatype="" displayformat="" id="grid1_cell_12_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="98" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>스튜디오드래곤-실적 추이 및 전망<br>ㅁ Investment Point: 1) OTT향 선판매 및 오리지널 리쿱율 상향, 2) 꾸준한 미국 시장 성과<br>ㅁ 1) 내년 1월부터 넷플릭스 오리지널 작품의 리쿱율 상향되며 작품당 마진 개선될 것으로 전망. 편성 축소에도 오리지널 및 선판매 작품의 리쿱율 상향으로 이익 단에서의 성장세 지속될 것으로 기대하며, 지역별 판매를 통해 견조한 수익성 시현 기대<br>ㅁ 2) 미국향 기획개발 IP 다수 보유하고 있으며, ‘The Big Door Prize S2’ 딜리버리 이후 매년 꾸준히 1편 이상의 시리즈 오더 받는 점 긍정적. 미국 시장에서의 성과 지속되는 점 주목할 만하며, 시작은 오리지널이지만 향후 자체 IP를 활용한 드라마 제작 기대</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_12_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="99" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_12_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="100" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>75,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_12_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="101" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>55,800</nobr></td><td datatype="text" displayformat="" id="grid1_cell_12_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="102" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>유진투자증권</nobr></td><td id="grid1_cell_12_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="103" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>이현지</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_13_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="104" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_13_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="105" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>오리온(271560)</nobr></td><td datatype="" displayformat="" id="grid1_cell_13_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="106" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>오리온-앞으로 시작될 조삼모사에 일희일비 금지<br>ㅁ 탑라인 부진에도 아홉 달 연속 증익 흐름 <br>ㅁ 레버리지 효과로 높은 기저를 뚫는다 <br>ㅁ 점유율 상승, 카테고리 및 지역 확장 가시화가 Key</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_13_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="107" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>매수</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_13_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="108" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>170,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_13_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="109" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>117,500</nobr></td><td datatype="text" displayformat="" id="grid1_cell_13_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="110" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>신한투자증권</nobr></td><td id="grid1_cell_13_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="111" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>조상훈</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_14_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="112" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_14_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="113" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>오리온(271560)</nobr></td><td datatype="" displayformat="" id="grid1_cell_14_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="114" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Orion-Look to the forest, beyond the trees<br>ㅁ Profit growth continues for the ninth month despite weak top line<br>ㅁ Strong operating leverage offsets high base effect<br>ㅁ Market share gains and category/regional expansion hold the key</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_14_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="115" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>매수</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_14_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="116" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>170,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_14_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="117" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>117,500</nobr></td><td datatype="text" displayformat="" id="grid1_cell_14_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="118" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Shinhan Investment &amp;</nobr></td><td id="grid1_cell_14_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="119" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>조상훈</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_15_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="120" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_15_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="121" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>오리온(271560)</nobr></td><td datatype="" displayformat="" id="grid1_cell_15_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="122" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>오리온-단기 실적 둔화 구간이나, 24년 성장에 대한 기대감 유지<br>ㅁ 오리온 10월 4개 법인 합산 매출액은 -3% y-y로 감소하고, 영업이익은 1% y-y 증가<br>ㅁ 비용 절감 노력이 지속되었음에도 불구, 환율 부담과, 명절 시점 차이로 인한 해외 매출액 감소로, 영업이익 성장이 다소 제한적이었음<br>ㅁ 4분기 단기 실적 둔화는 불가피할 것으로 예상되나, 환율과 같은 일회성 요인들이 제거될 24년 실적 개선에 대한 기대감은 유지</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_15_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="123" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_15_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="124" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>150,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_15_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="125" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>117,500</nobr></td><td datatype="text" displayformat="" id="grid1_cell_15_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="126" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성증권</nobr></td><td id="grid1_cell_15_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="127" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>최지호</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_16_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="128" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_16_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="129" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>오리온(271560)</nobr></td><td datatype="" displayformat="" id="grid1_cell_16_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="130" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Orion-Earnings growth temporarily slowing; 2024 optimism valid<br>ㅁ Preliminary October results-entering near-term earnings slowdown phase<br>ㅁ Domestic (38% of total sales)-sales growth stellar once again<br>ㅁ Overseas-results weak on negative forex and Lunar New Year effects</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_16_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="131" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_16_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="132" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>150,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_16_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="133" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>117,500</nobr></td><td datatype="text" displayformat="" id="grid1_cell_16_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="134" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성증권</nobr></td><td id="grid1_cell_16_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="135" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>최지호</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_17_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="136" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_17_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="137" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>오리온(271560)</nobr></td><td datatype="" displayformat="" id="grid1_cell_17_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="138" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>오리온-2024 Outlook<br>ㅁ 2024 Outlook <br>ㅁ 투자의견 BUY, 목표주가 180,000원 유지</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_17_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="139" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_17_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="140" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>180,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_17_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="141" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>117,500</nobr></td><td datatype="text" displayformat="" id="grid1_cell_17_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="142" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하이투자증권</nobr></td><td id="grid1_cell_17_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="143" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>이경신.이윤경</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_18_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="144" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_18_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="145" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>자이언트스텝(289220)</nobr></td><td datatype="" displayformat="" id="grid1_cell_18_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="146" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>자이언트스텝-B2C 모델로의 전환과 내년 턴어라운드<br>ㅁ 수주 기반 탈피해 B2C모델 본격화, 내년 턴어라운드 <br>ㅁ 단기 성장: 미디어 아트 전시 사업 통한 티켓매출 발생 <br>ㅁ 장기 성장: 버추얼 휴먼, 소셜네트워크게임도 내년 공개</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_18_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="147" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Not Rated</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_18_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="148" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr></nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_18_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="149" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>10,860</nobr></td><td datatype="text" displayformat="" id="grid1_cell_18_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="150" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>한국투자증권</nobr></td><td id="grid1_cell_18_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="151" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>안도영</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_19_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="152" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_19_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="153" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>카카오게임즈(293490)</nobr></td><td datatype="" displayformat="" id="grid1_cell_19_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="154" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>카카오게임즈-오딘만 살아남았다<br>ㅁ 2024년 매출액 1조 1,480억원(+13.4%yoy), 영업이익 1,279억원(+110%yoy) 전망<br>ㅁ 올해 매분기 출시된 ‘에버소울’, ‘아키에이지 워’, ‘아레스’는 출시 초기 양호환 매출 흐름을 보였지만, 잇따른 경쟁작 출시와 부정적인 국내 모바일 게임 시장 환경으로 짧은 게임수명을 보이며 빠르게 매출이 하락함<br>ㅁ 장르 및 플랫폼의 다각화와 글로벌 지역으로의 매출 확대를 장기 목표로 설정했지만, 본격적인 체질 변화까지는 시간이 다소 걸릴 것으로 전망. 투자의견 HOLD 및 목표가 24,000원 유지</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_19_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="155" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>HOLD</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_19_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="156" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>24,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_19_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="157" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>27,250</nobr></td><td datatype="text" displayformat="" id="grid1_cell_19_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="158" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>유진투자증권</nobr></td><td id="grid1_cell_19_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="159" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>정의훈</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_20_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="160" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_20_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="161" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>에이비엘바이오(298380)</nobr></td><td datatype="" displayformat="" id="grid1_cell_20_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="162" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>에이비엘바이오-확인될 BBB 플랫폼의 필요성<br>ㅁ 기업 현황 업데이트. 관심종목으로 제시<br>ㅁ 항암제부터 뇌질환 파이프라인을 확보한 이중항체 전문 기업. 임상 성과에 따라 추가 L/O 기대<br>ㅁ 에이비엘바이오는 이중항체 플랫폼 Grabody를 기반으로 면역항암제와 퇴행성뇌질환 등 다양한 치료제 개발 중</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_20_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="163" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Not Rated</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_20_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="164" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr></nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_20_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="165" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>19,490</nobr></td><td datatype="text" displayformat="" id="grid1_cell_20_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="166" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>다올투자증권</nobr></td><td id="grid1_cell_20_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="167" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>이지수.임도영</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_21_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="168" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_21_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="169" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>솔루엠(248070)</nobr></td><td datatype="" displayformat="" id="grid1_cell_21_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="170" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>솔루엠-24년에도 꺾이지 않는 성장<br>ㅁ 23년 영업이익 1,582억원(YoY 109%) 전망 <br>ㅁ 24년, ESL 성장 지속 &amp; 파워모듈 적용처 확대 본격화</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_21_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="171" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_21_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="172" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>42,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_21_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="173" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>28,350</nobr></td><td datatype="text" displayformat="" id="grid1_cell_21_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="174" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>키움증권</nobr></td><td id="grid1_cell_21_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="175" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>오현진</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_22_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="176" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_22_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="177" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>피에스케이(319660)</nobr></td><td datatype="" displayformat="" id="grid1_cell_22_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="178" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>피에스케이-시황은 여전히 불투명하지만, 내년 신장비 모멘텀 기대<br>ㅁ 상반기 이연된 매출 인식 영향, 하반기 개선된 실적 흐름 <br>ㅁ 고객 설비투자 전망은 여전히 불투명하나, 내년 신장비 모멘텀 기대 <br>ㅁ 긴 호흡에서 접근, 투자의견 ‘매수’ 및 목표주가 24,000원 유지</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_22_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="179" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>매수</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_22_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="180" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>24,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_22_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="181" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>20,850</nobr></td><td datatype="text" displayformat="" id="grid1_cell_22_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="182" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BNK투자증권</nobr></td><td id="grid1_cell_22_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="183" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>이민희</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_23_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="184" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_23_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="185" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>뷰노(338220)</nobr></td><td datatype="" displayformat="" id="grid1_cell_23_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="186" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>뷰노-무럭무럭 잘 자라고 있는 Deep CARS<br>ㅁ 매출액 전년대비 328% 상승, 영업적자 지속<br>ㅁ 12개월 선행 P/S 23배로 동사의 지난 2년 평균(14배)및 글로벌 Peer(6배) 대비 고평가 상태</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_23_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="187" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Not Rated</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_23_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="188" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr></nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_23_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="189" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>42,100</nobr></td><td datatype="text" displayformat="" id="grid1_cell_23_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="190" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>미래에셋증권</nobr></td><td id="grid1_cell_23_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="191" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>김충현</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_24_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="192" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_24_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="193" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>카카오뱅크(323410)</nobr></td><td datatype="" displayformat="" id="grid1_cell_24_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="194" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>카카오뱅크-현존하는 은행 중 영업을 가장 잘하는 은행<br>ㅁ 여/수신, 대주주, 중저신용자 대출 대한 질문 가장 많았음<br>ㅁ 압도적인 저원가성 수신 기반 NIM과 여신성장에서 경쟁력 부각<br>ㅁ 연말 정부 주도 주담대/전월대 플랫폼 출시도 동사에게 기회</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_24_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="195" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_24_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="196" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>36,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_24_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="197" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>26,000</nobr></td><td datatype="text" displayformat="" id="grid1_cell_24_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="198" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>대신증권</nobr></td><td id="grid1_cell_24_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="199" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>박혜진</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_25_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="200" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_25_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="201" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하이브(352820)</nobr></td><td datatype="" displayformat="" id="grid1_cell_25_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="202" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하이브-실적 추이 및 전망<br>ㅁ Investment Point: 1) 소속 아티스트 IP의 높은 성장성, 2) 미국 시장 성과(현지 레이블, 현지 걸그룹 데뷔), 3) 위버스 구독 서비스 본격화<br>ㅁ 1) 세븐틴, TXT, 르세라핌, 뉴진스 등 소속 아티스트 모두 폭발적인 성장 이어지며 본업 고성장 지속. 음반원과 더불어 공연에서의 모객 확대 기대되며 내년 6월 진 컴백을 시작으로 방탄소년단 부분적으로 활동 재개 기대<br>ㅁ 2) 인수한 미국 레이블들의 활동 본격적으로 시작되며 연결 실적 기여할 것으로 전망하며, 미국 현지 걸그룹 데뷔로 미국 시장 수익화 기대</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_25_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="203" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_25_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="204" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>330,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_25_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="205" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>200,000</nobr></td><td datatype="text" displayformat="" id="grid1_cell_25_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="206" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>유진투자증권</nobr></td><td id="grid1_cell_25_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="207" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>이현지</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_26_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="208" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_26_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="209" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>엔젠바이오(354200)</nobr></td><td datatype="" displayformat="" id="grid1_cell_26_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="210" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>엔젠바이오-NGS 기술력 기반 성장 기대감 지속<br>ㅁ NGS를 이용한 거의 모든 진단 분야에 대한 플랫폼 확보<br>ㅁ NGS 암 진단 관련 국내 경쟁력에도 불구하고 낮은 밸류<br>ㅁ 해외 진출이 Key Point, 미국은 클리아랩 인수를 통해 진행</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_26_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="211" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Not Rated</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_26_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="212" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr></nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_26_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="213" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>5,490</nobr></td><td datatype="text" displayformat="" id="grid1_cell_26_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="214" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>대신증권</nobr></td><td id="grid1_cell_26_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="215" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>한송협</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_27_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="216" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_27_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="217" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>퓨런티어(370090)</nobr></td><td datatype="" displayformat="" id="grid1_cell_27_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="218" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>퓨런티어-N년보다 (N+1)년<br>ㅁ 3Q23 별도 기준 실적은 매출액 108억원(+1.53%, YoY), 영업이익 15.2억원(흑자전환, YoY)을 기록<br>ㅁ 나무를 보지 말고 숲을 봐야 할 때<br>ㅁ 연간실적전망 올해보단 내년, 내년보단 후년</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_27_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="219" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Not Rated</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_27_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="220" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr></nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_27_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="221" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>34,750</nobr></td><td datatype="text" displayformat="" id="grid1_cell_27_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="222" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>한양증권</nobr></td><td id="grid1_cell_27_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="223" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>이준석</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_28_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="224" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_28_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="225" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>가온칩스(399720)</nobr></td><td datatype="" displayformat="" id="grid1_cell_28_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="226" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>가온칩스-NRE → Turn-Key<br>ㅁ 삼성파운드리 디자인솔루션 파트너<br>ㅁ 양산 매출 증가에 따른 가파른 외형성장 기대</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_28_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="227" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Not Rated</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_28_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="228" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr></nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_28_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="229" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>44,450</nobr></td><td datatype="text" displayformat="" id="grid1_cell_28_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="230" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>대신증권</nobr></td><td id="grid1_cell_28_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="231" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>이석영</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_29_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="232" or_wd="100" or_bgcolor=""><nobr>2023/11/22</nobr></td><td datatype="text" id="grid1_cell_29_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="233" or_wd="140" or_bgcolor=""><nobr>레고켐바이오사이언스(141080)</nobr></td><td datatype="" displayformat="" id="grid1_cell_29_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="234" or_wd="100" or_bgcolor=""><nobr>레고켐바이오-웃돈주고 사가는 ADC<br>ㅁ 거래에서 나타나는 빅파마의 관심 증가<br>ㅁ TROP2 L/O, HER ADC 데이터 기대</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_29_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="235" or_wd="100" or_bgcolor=""><nobr>Not Rated</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_29_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="236" or_wd="80" or_bgcolor=""><nobr></nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_29_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="237" or_wd="80" or_bgcolor=""><nobr>45,850</nobr></td><td datatype="text" displayformat="" id="grid1_cell_29_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="238" or_wd="100" or_bgcolor=""><nobr>키움증권</nobr></td><td id="grid1_cell_29_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="239" or_wd="50" or_bgcolor=""><nobr>허혜민</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255); display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_30_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="240" or_wd="100" style_bak="text-align:center;height:20px" or_bgcolor=""></td><td datatype="text" id="grid1_cell_30_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="241" or_wd="140" style_bak="text-align:left;height:20px" or_bgcolor=""></td><td datatype="" displayformat="" id="grid1_cell_30_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="242" or_wd="100" style_bak="text-align:left;height:20px" or_bgcolor=""></td><td datatyp="text" displayformat="" id="grid1_cell_30_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="243" or_wd="100" style_bak="text-align:left;height:20px" or_bgcolor=""></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_30_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="244" or_wd="80" style_bak="text-align:right;height:20px" or_bgcolor=""></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_30_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="245" or_wd="80" style_bak="text-align:right;height:20px" or_bgcolor=""></td><td datatype="text" displayformat="" id="grid1_cell_30_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="246" or_wd="100" style_bak="text-align:left;height:20px" or_bgcolor=""></td><td id="grid1_cell_30_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="247" or_wd="50" style_bak="text-align:left;height:20px" or_bgcolor=""></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_31_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="248" or_wd="100"></td><td datatype="text" id="grid1_cell_31_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="249" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_31_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="250" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_31_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="251" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_31_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="252" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_31_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="253" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_31_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="254" or_wd="100"></td><td id="grid1_cell_31_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="255" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_32_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="256" or_wd="100"></td><td datatype="text" id="grid1_cell_32_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="257" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_32_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="258" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_32_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="259" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_32_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="260" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_32_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="261" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_32_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="262" or_wd="100"></td><td id="grid1_cell_32_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="263" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_33_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="264" or_wd="100"></td><td datatype="text" id="grid1_cell_33_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="265" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_33_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="266" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_33_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="267" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_33_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="268" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_33_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="269" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_33_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="270" or_wd="100"></td><td id="grid1_cell_33_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="271" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_34_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="272" or_wd="100"></td><td datatype="text" id="grid1_cell_34_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="273" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_34_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="274" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_34_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="275" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_34_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="276" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_34_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="277" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_34_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="278" or_wd="100"></td><td id="grid1_cell_34_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="279" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_35_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="280" or_wd="100"></td><td datatype="text" id="grid1_cell_35_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="281" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_35_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="282" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_35_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="283" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_35_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="284" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_35_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="285" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_35_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="286" or_wd="100"></td><td id="grid1_cell_35_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="287" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_36_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="288" or_wd="100"></td><td datatype="text" id="grid1_cell_36_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="289" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_36_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="290" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_36_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="291" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_36_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="292" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_36_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="293" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_36_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="294" or_wd="100"></td><td id="grid1_cell_36_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="295" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_37_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="296" or_wd="100"></td><td datatype="text" id="grid1_cell_37_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="297" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_37_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="298" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_37_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="299" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_37_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="300" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_37_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="301" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_37_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="302" or_wd="100"></td><td id="grid1_cell_37_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="303" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_38_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="304" or_wd="100"></td><td datatype="text" id="grid1_cell_38_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="305" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_38_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="306" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_38_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="307" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_38_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="308" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_38_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="309" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_38_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="310" or_wd="100"></td><td id="grid1_cell_38_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="311" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_39_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="312" or_wd="100"></td><td datatype="text" id="grid1_cell_39_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="313" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_39_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="314" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_39_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="315" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_39_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="316" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_39_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="317" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_39_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="318" or_wd="100"></td><td id="grid1_cell_39_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="319" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_40_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="320" or_wd="100"></td><td datatype="text" id="grid1_cell_40_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="321" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_40_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="322" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_40_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="323" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_40_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="324" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_40_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="325" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_40_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="326" or_wd="100"></td><td id="grid1_cell_40_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="327" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_41_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="328" or_wd="100"></td><td datatype="text" id="grid1_cell_41_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="329" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_41_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="330" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_41_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="331" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_41_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="332" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_41_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="333" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_41_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="334" or_wd="100"></td><td id="grid1_cell_41_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="335" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_42_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="336" or_wd="100"></td><td datatype="text" id="grid1_cell_42_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="337" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_42_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="338" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_42_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="339" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_42_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="340" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_42_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="341" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_42_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="342" or_wd="100"></td><td id="grid1_cell_42_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="343" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_43_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="344" or_wd="100"></td><td datatype="text" id="grid1_cell_43_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="345" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_43_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="346" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_43_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="347" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_43_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="348" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_43_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="349" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_43_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="350" or_wd="100"></td><td id="grid1_cell_43_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="351" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_44_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="352" or_wd="100"></td><td datatype="text" id="grid1_cell_44_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="353" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_44_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="354" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_44_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="355" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_44_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="356" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_44_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="357" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_44_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="358" or_wd="100"></td><td id="grid1_cell_44_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="359" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_45_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="360" or_wd="100"></td><td datatype="text" id="grid1_cell_45_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="361" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_45_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="362" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_45_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="363" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_45_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="364" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_45_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="365" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_45_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="366" or_wd="100"></td><td id="grid1_cell_45_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="367" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_46_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="368" or_wd="100"></td><td datatype="text" id="grid1_cell_46_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="369" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_46_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="370" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_46_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="371" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_46_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="372" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_46_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="373" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_46_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="374" or_wd="100"></td><td id="grid1_cell_46_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="375" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_47_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="376" or_wd="100"></td><td datatype="text" id="grid1_cell_47_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="377" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_47_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="378" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_47_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="379" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_47_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="380" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_47_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="381" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_47_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="382" or_wd="100"></td><td id="grid1_cell_47_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="383" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_48_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="384" or_wd="100"></td><td datatype="text" id="grid1_cell_48_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="385" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_48_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="386" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_48_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="387" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_48_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="388" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_48_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="389" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_48_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="390" or_wd="100"></td><td id="grid1_cell_48_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="391" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_49_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="392" or_wd="100"></td><td datatype="text" id="grid1_cell_49_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="393" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_49_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="394" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_49_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="395" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_49_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="396" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_49_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="397" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_49_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="398" or_wd="100"></td><td id="grid1_cell_49_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="399" or_wd="50"></td></tr></tbody>